MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.freeradbiomed.2026.05.336

Медицинская библиотека · Free radical biology & medicine · 2026

Targeting mitochondrial ROS in the liver-brain axis attenuates inflammation and oxidative stress in covert hepatic encephalopathy.

Bai Yunhu, Wang Zhenhua, Guo Xiaofeng, Yang Ze, Xie Shuang, Zhang Huwei, Nan Bo, Zhang Ning, Li Ang, Wang Quanhui, Zhang Chunxu

СтатьяПеревод в очереди

Аннотация

Covert hepatic encephalopathy (CHE) is a debilitating complication of chronic liver disease, in which hyperammonemia and oxidative stress play central pathogenic roles. While mitochondria-targeted antioxidants show promise in mitigating multi-organ injury, their efficacy in CHE remains insufficiently studied. To address this gap, this study analyzed clinical samples and observed significant dysregulation of peripheral oxidative stress markers in cirrhotic patients with hyperammonemia. Subsequently, in vitro experiments demonstrated that the mitochondria-targeted antioxidant MitoQ effectively attenuated ammonia-induced mitochondrial reactive oxygen species overproduction, loss of membrane potential, and impaired ATP synthesis in neuronal cells. In a bile duct ligation-induced mouse model of CHE, MitoQ administration not only alleviated hepatic injury and fibrosis but also concurrently reduced oxidative stress and inflammatory cytokine levels in the liver, blood, and brain. These changes were accompanied by marked improvements in motor coordination and systemic energy metabolism stability. Collectively, our findings indicate that MitoQ exerts multi-organ protective effects by targeting mitochondrial ROS along the liver-brain axis, restoring redox homeostasis and suppressing inflammation, thereby proposing a novel integrated therapeutic strategy for CHE. This study contributes to the mechanistic understanding of liver-brain crosstalk in HE and offers preliminary preclinical evidence that suggests a potential role for mitochondrial-targeted antioxidants in the management of hepatic encephalopathy, which also require independent validation in larger cohorts.

Для цитирования: Bai Yunhu, Wang Zhenhua, Guo Xiaofeng, Yang Ze, Xie Shuang, Zhang Huwei, Nan Bo, Zhang Ning, Li Ang, Wang Quanhui, Zhang Chunxu. Targeting mitochondrial ROS in the liver-brain axis attenuates inflammation and oxidative stress in covert hepatic encephalopathy.. Free radical biology & medicine. 2026. DOI: 10.1016/j.freeradbiomed.2026.05.336.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.